loperamide
SMILES | Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 |
InChIKey | RDOIQAHITMMDAJ-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 3 |
Hydrogen bond donors | 1 |
Rotatable bonds | 7 |
Molecular weight (Da) | 476.2 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
μ | OPRM | Human | Opioid | A | pKi | 9.28 | 9.28 | 9.28 | Guide to Pharmacology |
α1B | ADA1B | Rat | Adrenoceptors | A | pKi | 6.27 | 6.27 | 6.27 | ChEMBL |
α1A | ADA1A | Rat | Adrenoceptors | A | pKi | 5.6 | 5.6 | 5.6 | ChEMBL |
H2 | HRH2 | Human | Histamine | A | pKi | 5.52 | 5.52 | 5.52 | ChEMBL |
μ | OPRM | Rat | Opioid | A | pKi | 9.8 | 9.8 | 9.8 | ChEMBL |
D4 | DRD4 | Human | Dopamine | A | pKi | 5.73 | 5.73 | 5.73 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 5.58 | 5.58 | 5.58 | ChEMBL |
β2 | ADRB2 | Human | Adrenoceptors | A | pKi | 5.68 | 5.68 | 5.68 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pKi | 5.71 | 6.03 | 6.34 | ChEMBL |
δ | OPRD | Human | Opioid | A | pKi | 6.5 | 6.5 | 6.5 | ChEMBL |
κ | OPRK | Human | Opioid | A | pKi | 5.9 | 5.9 | 5.9 | ChEMBL |
μ | OPRM | Human | Opioid | A | pKi | 9.23 | 9.36 | 9.57 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pKi | 5.24 | 5.24 | 5.24 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 8.25 | 8.25 | 8.25 | Drug Central |
α1D | ADA1D | Human | Adrenoceptors | A | pKi | 8.25 | 8.25 | 8.25 | Drug Central |
β2 | ADRB2 | Human | Adrenoceptors | A | pKi | 8.25 | 8.25 | 8.25 | Drug Central |
D3 | DRD3 | Human | Dopamine | A | pKi | 8.2 | 8.2 | 8.2 | Drug Central |
H2 | HRH2 | Human | Histamine | A | pKi | 8.26 | 8.26 | 8.26 | Drug Central |
δ | OPRD | Human | Opioid | A | pKi | 8.16 | 8.16 | 8.16 | Drug Central |
κ | OPRK | Human | Opioid | A | pKi | 8.17 | 8.17 | 8.17 | Drug Central |
μ | OPRM | Human | Opioid | A | pKi | 8.05 | 8.05 | 8.05 | Drug Central |
SST5 | SSR5 | Human | Somatostatin | A | pKi | 8.27 | 8.27 | 8.27 | Drug Central |
μ | OPRM | Rat | Opioid | A | pKi | 8.01 | 8.01 | 8.01 | Drug Central |
α1B | ADA1B | Rat | Adrenoceptors | A | pKi | 8.2 | 8.2 | 8.2 | Drug Central |
H1 | HRH1 | Human | Histamine | A | pKi | 5.7 | 5.7 | 5.7 | PDSP Ki database |
δ | OPRD | Rat | Opioid | A | pKi | 8.14 | 8.14 | 8.14 | Drug Central |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
α1B | ADA1B | Rat | Adrenoceptors | A | pIC50 | 6.01 | 6.01 | 6.01 | ChEMBL |
α1A | ADA1A | Rat | Adrenoceptors | A | pIC50 | 5.21 | 5.21 | 5.21 | ChEMBL |
M1 | ACM1 | Rat | Acetylcholine (muscarinic) | A | Potency | 4.7 | 4.75 | 4.8 | ChEMBL |
H2 | HRH2 | Human | Histamine | A | pIC50 | 5.51 | 5.51 | 5.51 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pIC50 | 5.39 | 5.39 | 5.39 | ChEMBL |
β2 | ADRB2 | Human | Adrenoceptors | A | pIC50 | 5.52 | 5.52 | 5.52 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pIC50 | 5.87 | 5.87 | 5.87 | ChEMBL |
δ | OPRD | Human | Opioid | A | pIC50 | 6.05 | 6.48 | 6.91 | ChEMBL |
δ | OPRD | Human | Opioid | A | pEC50 | 6.81 | 6.81 | 6.81 | ChEMBL |
NPS | NPSR1 | Human | Neuropeptide S | A | Potency | 5.0 | 5.0 | 5.0 | ChEMBL |
κ | OPRK | Human | Opioid | A | pIC50 | 5.5 | 6.15 | 6.81 | ChEMBL |
μ | OPRM | Human | Opioid | A | pIC50 | 8.82 | 8.83 | 8.84 | ChEMBL |
H1 | HRH1 | Human | Histamine | A | pIC50 | 8.24 | 8.24 | 8.24 | Drug Central |
α1A | ADA1A | Rat | Adrenoceptors | A | pIC50 | 8.28 | 8.28 | 8.28 | Drug Central |
TSH | TSHR | Human | Glycoprotein hormone | A | Potency | 4.4 | 5.4 | 5.9 | ChEMBL |